Construction has begun on 275 Dan Road in Canton, which will serve as the world’s largest automated living cell manufacturing plant.

The plant will serve as Organogenesis Inc.’s new global headquarters, according to a statement. Cambridge-based SMMA/Symmes Maini & McKee Assoc. will serve as the architect and CRB Consulting Engineers Inc. will serve as the engineers for the project.

Organogenesis also purchased 65 Dan Road in Canton. Approximately 30 percent of the 78,000-square-foot building will be used for warehousing and storage with additional space to accommodate the company’s growth. The acquisition of 65 Dan Road brings the company’s total headquarters size to four buildings, comprising 330,000 square feet of space, according to a statement.

"This is an exciting day both for Organogenesis and for the commonwealth," said Gov. Deval Patrick. "Massachusetts will soon be home to a landmark manufacturing facility that will produce living technology that advances healing around the world, while at the same time creating jobs and expansion here at home. This is just the sort of innovation and job creation that our Life Sciences Initiative was designed to encourage."

"This is a huge milestone for Organogenesis, as well as for the commonwealth and for the regenerative medicine industry as a whole," said Organogenesis President and CEO Geoff MacKay. "We’re growing in Massachusetts in size, in revenue and capacity; and in order to keep pace with our rapid growth, we’re hiring across all departments."

Organogenesis is in the midst of a major, multi-year expansion of its global headquarters, R&D and manufacturing facilities, according to a statement. The company estimates its total investment in the two-phased expansion will be approximately $63 million.

The 275 Dan Road project is expected to be completed in 2013.